✦ LIBER ✦

292 Long-term effect of ursodeoxycholic acid on the Cystic Fibrosis related Liver Disease

Book ID: 118640413
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 91 KB
Volume: 4
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(05)80259-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ursodeoxycholic acid therapy

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

✍ Carla Colombo; Kenneth D.R. Setchell; Mauro Podda; Andrea Crosignani; Aldo Roda; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 685 KB

Ursodeoxycholic acid therapy in cystic f

Ursodeoxycholic acid therapy in cystic fibrosis liver disease – a retrospective long-term follow-up case-control study

✍ M. Kappler; C. Espach; A. Schweiger-Kabesch; T. Lang; D. Hartl; A. Hector; C. Gl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Effect of long-term therapy of cholestat

Effect of long-term therapy of cholestatic liver diseases with ursodeoxycholic acid

✍ Miloshevski, Mitko; Serafimoski, Vladimir; Trajanovski, Dragoljub; Vasilevski, V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 189 KB

The benign course of liver disease in ad

The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid

✍ Christopher Paul Desmond; John Wilson; Michael Bailey; Denise Clark; Stuart Keit 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Effects of ursodeoxycholic acid on liver

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

✍ C. Galabert; J.C. Montet; D. Lengrand; A. Lecuire; C. Sotta; C. Figarella; J.P. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 333 KB

A two-year prospective study of the effe

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis–associated liver disease

✍ Anders Lindblad; Hans Glaumann; Birgitta Strandvik 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 1 views

The efficacy of 2 years of treatment with ursodeoxycholic acid (UDCA) in cystic fibrosis (CF)-associated liver disease was evaluated by liver biopsies and liver function tests in 10 patients aged 8 to 28 years. The metabolism of UDCA was investigated by analysis of urinary bile acids with fast atom